NEW YORK, July 13, 2020 /PRNewswire/ -- A drug used to treat (SLE) significantly reduces the incidence of a rare and sometimes fatal heart condition in newborn babies, a new study from NYU Grossman School of Medicine researchers shows. The condition, called congenital heart block (CHB), results in a lower than normal heart rate and affects as many as one in 15,000 live births, study investigators say. Normal resting heart rate for newborns, they point out, is 120 heartbeats to 160 heartbeats per minute, but a heart rate below 50 heartbeats per minute can be fatal for a fetus. Of the babies born with low heart rates who survive, about 75 percent will require at least one pacemaker during...
|
